Quantum Biopharma (QNTM) Times Interest Earned (2019 - 2026)
Quantum Biopharma (QNTM) posted Times Interest Earned of -$129.79 for Q1 2026, down 497.23% sequentially from $32.67 in Q4 2025, and up 3.06% YoY from -$125.94 in Q1 2025.
Quantum Biopharma (QNTM) Times Interest Earned (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Times Interest Earned for 8 years, with the latest figure at -$129.79 in Q1 2026.
- Quarterly Times Interest Earned rose 3.06% year-over-year to -$129.79 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$93.68 (up 67.19% YoY) and the FY2025 annual result came in at -$96.81, up 80.19% from the prior year.
- Times Interest Earned eased to -$129.79 in Q1 2026 per QNTM's latest filing, from $32.67 in the prior quarter.
- Over five years, Times Interest Earned peaked at $8715.5 in Q3 2023 and troughed at -$11275.2 in Q4 2023.
- A 5-year average of -$681.39 and a median of -$133.89 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2025: Times Interest Earned slumped 1540.4% in 2023, then jumped 102.93% in 2025.
- Over 5 years, Times Interest Earned stood at $288.03 in 2022, then tumbled by 4014.62% to -$11275.2 in 2023, then surged by 90.11% to -$1115.4 in 2024, then surged by 102.93% to $32.67 in 2025, then slumped by 497.23% to -$129.79 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$129.79, $32.67, and -$51.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | -27.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.79 |
| Dec 31, 2025 | 32.67 |
| Sep 30, 2025 | -51.09 |
| Jun 30, 2025 | -41.50 |
| Mar 31, 2025 | -133.89 |
| Dec 31, 2024 | -1,115.43 |
| Sep 30, 2024 | -403.15 |
| Jun 30, 2024 | -413.62 |
| Mar 31, 2024 | -181.84 |
| Dec 31, 2023 | -11,275.19 |
| Sep 30, 2023 | 8,715.47 |
| Mar 31, 2023 | -4,148.75 |
| Mar 31, 2022 | 288.03 |
| Jun 30, 2021 | -670.79 |
| Mar 31, 2021 | 507.25 |
| Sep 30, 2020 | -215.74 |
| Jun 30, 2020 | -70.52 |
| Mar 31, 2020 | -68.74 |
| Dec 31, 2019 | -137.41 |
| Sep 30, 2019 | -115.99 |